| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | F H J Claas | |
| A R Tambur | |||
| P2860 | cites work | MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides | Q24813031 |
| HLA antibody detection with solid phase assays: great expectations or expectations too great? | Q27015921 | ||
| Specificity pockets for the side chains of peptide antigens in HLA-Aw68 | Q27700642 | ||
| Maximizing the benefits of HLA matching for renal transplantation: alleles, specificities, cregs, epitopes, or residues | Q33768849 | ||
| On the definition of a criterion of immunogenicity | Q34000887 | ||
| HLA and cross-reactive antigen group matching for cadaver kidney allocation | Q34257065 | ||
| Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation | Q34275797 | ||
| B cell positive selection: road map to the primary repertoire? | Q35813479 | ||
| A structurally based approach to determine HLA compatibility at the humoral immune level | Q36316220 | ||
| Public antigenic determinant on a family of HLA-B molecules | Q37042224 | ||
| The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity | Q37943469 | ||
| Detection of donor-specific antibodies in kidney transplantation | Q38204851 | ||
| Human Histocompatibility Antigens of Leukocytes | Q39981444 | ||
| Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies | Q40360031 | ||
| The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder | Q40802303 | ||
| Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802]. | Q41287716 | ||
| Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes | Q41730023 | ||
| HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes | Q42665365 | ||
| Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept | Q44844892 | ||
| Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens | Q46135152 | ||
| Antibody-antigen interactions: contact analysis and binding site topography. | Q47628744 | ||
| The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens | Q47683551 | ||
| Epitope analysis of HLA-DQ antigens: what does the antibody see? | Q48601896 | ||
| The DQ barrier: improving organ allocation equity using HLA-DQ information. | Q51280535 | ||
| High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. | Q51540153 | ||
| Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets | Q51639128 | ||
| Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. | Q51775005 | ||
| Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. | Q51824278 | ||
| HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. | Q52019798 | ||
| The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. | Q52041496 | ||
| HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. | Q52041499 | ||
| Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? | Q53217713 | ||
| The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. | Q54410910 | ||
| Toward HLA epitope matching in clinical transplantation. | Q54712641 | ||
| The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens | Q59092174 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1148-1154 | |
| P577 | publication date | 2015-02-23 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | HLA epitopes as viewed by antibodies: what is it all about? | |
| P478 | volume | 15 |
| Q41676635 | A Novel Method for Anti-HLA Antibody Detection Using Personalized Peptide Arrays |
| Q37252505 | Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching |
| Q99711560 | Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study |
| Q30277267 | Approach to the Highly Sensitized Kidney Transplant Candidate |
| Q28563989 | B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38726059 | Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation. |
| Q89425395 | HLA and lung transplantation |
| Q89472835 | HLA in transplantation |
| Q93387278 | HLA-B*44:138Q: Evidence for a confined deletion and recombination events in an otherwise unaffected HLA-haplotype |
| Q51707732 | Hiding in Plain Sight-A New Look at HLA Epitopes: A Case Report. |
| Q52687437 | Human HLA-B27 typing using the BD™ HLA-B27 kit on the BD FACSVia™ system: A multicenter study. |
| Q46429041 | Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs. |
| Q47795834 | Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation |
| Q52310243 | Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. |
| Q40594003 | Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program |
| Q47654607 | Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation |
| Q95293724 | Predictive value of HLAMatchmaker and PIRCHE-II scores for de novo donor-specific antibody formation after adult and pediatric liver transplantation |
| Q92112499 | Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: A mini-review |
| Q48397261 | The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients |
| Q28830861 | The European Hematology Association Roadmap for European Hematology Research: a consensus document |
| Q42317060 | The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA. |
| Q57811762 | The long and winding road towards epitope matching in clinical transplantation |
Search more.